Li Yuanhang, Bai Weijun, Zhang Jianjun
Cancer Hospital of China Medical University, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, PR China; Liaoning Cancer Hospital & Insititute, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, PR China.
Cancer Hospital of China Medical University, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, PR China; Liaoning Cancer Hospital & Insititute, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, PR China.
Biomed Pharmacother. 2017 Aug;92:1038-1044. doi: 10.1016/j.biopha.2017.05.092. Epub 2017 Jun 10.
To explore the biological functions of miR-200c-5p/MAD2L1 axis on the proliferation and metastasis of human hepatocellular carcinoma (HCC) cells.
The expression levels of miR-200c-5p and MAD2L1 in HCC tissues, adjacent tissues as well as HCC cell lines were detected by RT-qPCR or Western blot. The interaction between miR-200c-5p and MAD2L1 was verified by dual luciferase reporter gene system. Transfection was performed to manipulate the expression of miR-200c-5p and MAD2L1 in HCCLM3 cells. Colony formation, MTT, wound healing and Transwell assays were applied to measure the cell proliferation, migration and invasion of HCC, besides, flow cytometry analysis was also conducted to evaluate HCC cell cycle and apoptosis.
Low expression of miR-200c-5p and remarkable overexpression of MAD2L1 was uncovered in HCC tissues and cells compared with the normal. The aberrant expression of miR-200c-5p and MAD2L1 was correlated with tumor stage, adjacent organ invasion and prognosis. Direct target relationship between miR-200c-5p and MAD2L1 was confirmed by dual luciferase reporting assay. Up-regulation of miR-200c-5p downregulated MAD2L1 and suppressed the proliferation, migration, invasion and induced apoptosis and cell cycle arrest of HCC cells. Moreover, MAD2L1 promoted HCC cell viabilities and co-transfection of MAD2L1 restored the anti-tumor effects of miR-200c-5p overexpression.
Replenishing of miR-200c-5p inhibited the proliferation, migration and invasion of HCC cells by suppressing MAD2L1. MiR-200c-5p can serve as a prognostic indicator and a promising therapeutic target for HCC patients.
探讨miR-200c-5p/MAD2L1轴对人肝癌(HCC)细胞增殖和转移的生物学功能。
采用RT-qPCR或蛋白质免疫印迹法检测HCC组织、癌旁组织以及HCC细胞系中miR-200c-5p和MAD2L1的表达水平。通过双荧光素酶报告基因系统验证miR-200c-5p与MAD2L1之间的相互作用。对HCCLM3细胞进行转染以调控miR-200c-5p和MAD2L1的表达。应用集落形成实验、MTT实验、划痕实验和Transwell实验检测HCC细胞的增殖、迁移和侵袭能力,此外,还进行流式细胞术分析以评估HCC细胞周期和凋亡情况。
与正常组织和细胞相比,HCC组织和细胞中miR-200c-5p表达降低,MAD2L1显著过表达。miR-200c-5p和MAD2L1的异常表达与肿瘤分期、邻近器官侵犯及预后相关。双荧光素酶报告实验证实miR-200c-5p与MAD2L1之间存在直接靶向关系。上调miR-200c-5p可下调MAD2L1表达,并抑制HCC细胞的增殖、迁移、侵袭,诱导细胞凋亡和细胞周期阻滞。此外,MAD2L1促进HCC细胞活力,共转染MAD2L1可恢复miR-200c-5p过表达的抗肿瘤作用。
补充miR-200c-5p通过抑制MAD2L1抑制HCC细胞的增殖、迁移和侵袭。MiR-200c-5p可作为HCC患者的预后指标和有前景的治疗靶点。